Biopharma Beckons Bears Before Third-Quarter Report

Short interest accounts for over 15% of the stock's total float

Managing Editor
Nov 4, 2019 at 11:29 AM
facebook twitter linkedin

Biopharmaceutical name Amarin Corporation plc (NASDAQ:AMRN) has had a volatile year on the charts. Stuck in a series of higher lows since early August, the AMRN is failing to fully recover from two drastic bear gaps seen earlier this year. While the $14 has cushioned drastic pullbacks of late, AMRN looks to be once again approaching a key level -- one which tends to have historically bearish implications. 

Amarin stock is up 2% this afternoon, last seen at $17.11. Per data from Schaeffer's Senior Quantitative Analyst Rocky White, this positive price action is likely to be short lived. AMRN is now within one standard deviation of the 200-day moving average. According to White, there have been two other times during the past three years the stock has tested resistance at its 200-day, and was lower one month later 100% of the time, with an average loss of 8.1%. Another drop of this magnitude would put the shares back near $15.73  by early December.

daily AMRN with 200MA

Amarin is also joining the slew of this week's earnings reports, slated to reveal third-quarter results before the open tomorrow, Nov. 5. AMRN has closed higher the day after reporting in six of the past eight quarters, averaging a swing of 4.8%, regardless of direction. This time around, the options market is pricing in a larger-than-usual 8.8% move, based on near-term straddle pricing.

All seven analysts following AMRN sport a "strong buy" recommendation on the stock. This positive sentiment is echoed with the stock's average 12-month price target of $29.11 a nearly 70% premium to current levels. In other words, the equity could be ripe for a fresh serving of downgrades and/or price-target cuts. 

Lastly, while short interest has dropped 2.5% during the most recent reporting period, it now accounts for 15.5% of the stock's total available float. At Amarin stock's average daily trading volume, it would take short sellers almost eight days to buy back their bearish bets.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners